BackElicio Therapeutics Overview

Elicio Therapeutics Current Cash

Elicio Therapeutics's current cash is $23M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$23.48M
↑ 6.30% YoYΔ $1.39M vs prior year quarter

Peer trimmed avg / median

Loading

Elicio Therapeutics Current Cash History

Loading

Elicio Therapeutics vs. peers: Current Cash Comparison

Loading

Elicio Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Elicio Therapeutics (ELTX) FAQ

As of the most recent data (June 2026), ELTX shows a current cash of $23M. That compares with $22M in the prior-year period — up 6.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ELTX's current cash is now $23M (was $22M) — a 6.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Elicio Therapeutics is outperforming or lagging.

Tracking ELTX's current cash over time shows whether Elicio Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $23M That compares with $22M in the prior-year period — up 6.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Elicio Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $23M) with ownership activity and broader fundamentals.